Paysign 10-Q: Q3 Beat Confirmed, But a Plasma Customer Is Pulling 113 Centers
PAYS has more than doubled off its 52-week low of $3.08 on elevated volume (3.2× avg).
Summary
Paysign's 10-Q confirms the already-announced Q3 beat (revenue $30.8M, +42.6%; net income $6.7M) and discloses that a plasma customer will move 113 donation centers to a rival by December 31, 2026, cutting revenue and gross profit from Q4 onward.
Key Events · Earnings and Guidance · PAYS
-
Q3 Results Confirm Prior Release
Revenue of $30,800,158, up 42.6% from $21,596,478; net income of $6,735,694 versus $2,215,135; diluted EPS of $0.11 versus $0.04.
-
Plasma Customer Exiting 113 Centers
A plasma customer notified Paysign in October 2026 it will transition 113 donation centers to another provider by December 31, 2026; those centers generated about $2.8M revenue and $1.3M gross profit in Q3 2026 and $8.5M revenue and $3.9M gross profit for the nine months.
-
Cash Generation and Balance Sheet
Nine-month operating cash flow of $82,831,431 versus $4,360,171 a year earlier; unrestricted cash of $34,539,557 at September 30, 2026, up $13,471,906 from December 31, 2025.
-
Gamma Earn-Out Terminated
The Gamma Innovation earn-out was terminated June 30, 2026 with the liability at $0; the nine-month period includes a $990,000 non-cash reduction to SG&A from the fair-value change.
Analysis · PAYS · Trade & Services
The quarter itself was already public and strong: revenue up 42.6% to $30.8M, operating income of $7.3M versus $1.6M, net income of $6.7M. What is new in the 10-Q is buried in the subsequent-events note — a plasma customer told Paysign in October it will move 113 donation centers to another provider by December 31, 2026. Those centers produced about $2.8M of revenue and $1.3M of gross profit in Q3 alone, roughly 9% of quarterly revenue, and the company says the loss will cut revenue and gross profit starting in Q4 and continuing into 2027. That turns a clean beat into a growth question: pharma is now the bigger and faster-growing segment, but plasma is the legacy base and this is a real hole to fill. Cash generation is not the issue — nine-month operating cash flow was $82.8M and unrestricted cash rose to $34.5M — so the debate is revenue durability, not liquidity.
How filings like this one have moved
In the 30 days to Nov 15, 2026, 48.2% of the 1980 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.20%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, PAYS was trading at $13.48 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $706.3M. The 52-week trading range was $3.08 to $16.15. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.